Discounted Cash Flow (DCF) Analysis Levered
Chembio Diagnostics, Inc. (CEMI)
$0.455
+0.00 (+0.22%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 33.41 | 34.46 | 30.45 | 47.82 | 49.52 | 55.97 | 63.27 | 71.51 | 80.82 | 91.35 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -11.78 | -9.06 | -18.89 | -30.89 | -12.69 | -23.93 | -27.05 | -30.57 | -34.56 | -39.06 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -1.47 | -3.80 | -4.17 | -4.64 | -4.80 | -5.43 | -6.14 | -6.94 | -7.84 | -8.86 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -13.25 | -12.86 | -23.05 | -35.52 | -17.50 | -29.36 | -33.19 | -37.51 | -42.40 | -47.92 |
Weighted Average Cost Of Capital
| Share price | $ 0.455 |
|---|---|
| Beta | 1.857 |
| Diluted Shares Outstanding | 24.30 |
| Cost of Debt | |
| Tax Rate | -0.15 |
| After-tax Cost of Debt | 1.52% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 12.454 |
| Total Debt | 25.08 |
| Total Equity | 11.06 |
| Total Capital | 36.14 |
| Debt Weighting | 69.41 |
| Equity Weighting | 30.59 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 33.41 | 34.46 | 30.45 | 47.82 | 49.52 | 55.97 | 63.27 | 71.51 | 80.82 | 91.35 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.78 | -9.06 | -18.89 | -30.89 | -12.69 | -23.93 | -27.05 | -30.57 | -34.56 | -39.06 |
| Capital Expenditure | -1.47 | -3.80 | -4.17 | -4.64 | -4.80 | -5.43 | -6.14 | -6.94 | -7.84 | -8.86 |
| Free Cash Flow | -13.25 | -12.86 | -23.05 | -35.52 | -17.50 | -29.36 | -33.19 | -37.51 | -42.40 | -47.92 |
| WACC | ||||||||||
| PV LFCF | -28 | -30.18 | -32.52 | -35.05 | -37.78 | |||||
| SUM PV LFCF | -163.53 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 4.87 |
| Free cash flow (t + 1) | -48.88 |
| Terminal Value | -1,703.09 |
| Present Value of Terminal Value | -1,342.71 |
Intrinsic Value
| Enterprise Value | -1,506.24 |
|---|---|
| Net Debt | 6.90 |
| Equity Value | -1,513.14 |
| Shares Outstanding | 24.30 |
| Equity Value Per Share | -62.27 |